Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.

Kobayashi T, Kuroda J, Fuchida SI, Kaneko H, Yagi H, Shibayama H, Tanaka H, Kosugi S, Uoshima N, Kobayashi M, Adachi Y, Ohta K, Ishii K, Uchiyama H, Matsuda M, Nakatani E, Tsudo M, Shimazaki C, Takaori-Kondo A, Nomura S, Matsumura I, Taniwaki M, Kanakura Y; KMF investigators.

Int J Hematol. 2014 Nov 11. [Epub ahead of print]

PMID:
25385278
[PubMed - as supplied by publisher]
2.

The pathological role of IL-18Rα in renal ischemia/reperfusion injury.

Yano T, Nozaki Y, Kinoshita K, Hino S, Hirooka Y, Niki K, Shimazu H, Kishimoto K, Funauch M, Matsumura I.

Lab Invest. 2014 Oct 20. doi: 10.1038/labinvest.2014.120. [Epub ahead of print]

PMID:
25329004
[PubMed - as supplied by publisher]
3.

Treatment of chronic myeloid leukemia in chronic phase.

Matsumura I.

Rinsho Ketsueki. 2014 Oct;55(10):1853-9. No abstract available.

PMID:
25297749
[PubMed - in process]
4.

Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: signs of antisynthetase syndrome.

Kato M, Oiso N, Nozaki Y, Inoue A, Hosono Y, Funauchi M, Mimori T, Matsumura I, Kawada A.

J Dermatol. 2014 Nov;41(11):1034-6. doi: 10.1111/1346-8138.12626. Epub 2014 Oct 8. No abstract available.

PMID:
25294403
[PubMed - in process]
5.

Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells.

Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, Shimada T, Tanimura A, Matsui K, Yokota T, Oritani K, Tanabe K, Watanabe T, Kanakura Y, Matsumura I.

PLoS One. 2014 Oct 3;9(10):e109441. doi: 10.1371/journal.pone.0109441. eCollection 2014.

PMID:
25279552
[PubMed - in process]
Free PMC Article
6.

Transformable facultative thermophile Geobacillus stearothermophilus NUB3621 as a host strain for metabolic engineering.

Blanchard K, Robic S, Matsumura I.

Appl Microbiol Biotechnol. 2014 Aug;98(15):6715-23. doi: 10.1007/s00253-014-5746-z. Epub 2014 May 2.

PMID:
24788326
[PubMed - in process]
7.

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Sakurai M, Kunimoto H, Watanabe N, Fukuchi Y, Yuasa S, Yamazaki S, Nishimura T, Sadahira K, Fukuda K, Okano H, Nakauchi H, Morita Y, Matsumura I, Kudo K, Ito E, Ebihara Y, Tsuji K, Harada Y, Harada H, Okamoto S, Nakajima H.

Leukemia. 2014 Dec;28(12):2344-54. doi: 10.1038/leu.2014.136. Epub 2014 Apr 15.

PMID:
24732596
[PubMed - in process]
8.

Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice.

Nozaki Y, Kitching AR, Akiba H, Yagita H, Kinoshita K, Funauchi M, Matsumura I.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1210-21. doi: 10.1152/ajprenal.00570.2013. Epub 2014 Mar 12.

PMID:
24623145
[PubMed - indexed for MEDLINE]
9.

Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.

Nozaki Y, Kinoshita K, Yano T, Shiga T, Hino S, Niki K, Kishimoto K, Funauchi M, Matsumura I.

Lupus. 2014 Mar 5;23(8):769-777. [Epub ahead of print]

PMID:
24598218
[PubMed - as supplied by publisher]
10.

[Immune evasion of Pseudomonas aeruginosa].

Shimada T, Matsumura I.

Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(1):33-41. Review. Japanese.

PMID:
24598066
[PubMed - indexed for MEDLINE]
Free Article
11.

Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.

Kuroda J, Shimura Y, Ohta K, Tanaka H, Shibayama H, Kosugi S, Fuchida S, Kobayashi M, Kaneko H, Uoshima N, Ishii K, Nomura S, Taniwaki M, Takaori-Kondo A, Shimazaki C, Tsudo M, Hino M, Matsumura I, Kanakura Y; Kansai Myeloma Forum Investigators.

Int J Hematol. 2014 Apr;99(4):441-9. doi: 10.1007/s12185-014-1539-5. Epub 2014 Mar 1.

PMID:
24584872
[PubMed - in process]
12.

Escherichia coli deletion mutants illuminate trade-offs between growth rate and flux through a foreign anabolic pathway.

Falls KC, Williams AL, Bryksin AV, Matsumura I.

PLoS One. 2014 Feb 4;9(2):e88159. doi: 10.1371/journal.pone.0088159. eCollection 2014.

PMID:
24505410
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis.

Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Ishibashi T, Sudo T, Yokota T, Ezoe S, Tanaka H, Matsumura I, Oritani K, Kanakura Y.

Exp Hematol. 2014 May;42(5):410-422.e4. doi: 10.1016/j.exphem.2014.01.002. Epub 2014 Jan 16.

PMID:
24440520
[PubMed - indexed for MEDLINE]
14.

Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costs.

Kramer JR, Matsumura I.

PLoS One. 2013 Oct 18;8(10):e76687. doi: 10.1371/journal.pone.0076687. eCollection 2013.

PMID:
24204655
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Overlap extension PCR cloning.

Bryksin A, Matsumura I.

Methods Mol Biol. 2013;1073:31-42. doi: 10.1007/978-1-62703-625-2_4.

PMID:
23996437
[PubMed - indexed for MEDLINE]
16.

The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.

Satoh Y, Yokota T, Sudo T, Kondo M, Lai A, Kincade PW, Kouro T, Iida R, Kokame K, Miyata T, Habuchi Y, Matsui K, Tanaka H, Matsumura I, Oritani K, Kohwi-Shigematsu T, Kanakura Y.

Immunity. 2013 Jun 27;38(6):1105-15. doi: 10.1016/j.immuni.2013.05.014. Epub 2013 Jun 20.

PMID:
23791645
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Substrate ambiguous enzymes within the Escherichia coli proteome offer different evolutionary solutions to the same problem.

Yip SH, Matsumura I.

Mol Biol Evol. 2013 Sep;30(9):2001-12. doi: 10.1093/molbev/mst105. Epub 2013 May 31.

PMID:
23728795
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Relationship between red blood cell transfusion volume and posttransfusional iron overload in hematological diseases].

Ashida T, Kawano A, Yamada E, Ide D, Sugano C, Kato Y, Tsubakimoto Y, Ito S, Mine Y, Fujita M, Kanemitsu Y, Morishima Y, Morita Y, Tanaka H, Shimada T, Kawanishi K, Miyatake J, Tatsumi Y, Matsumura I.

Rinsho Ketsueki. 2013 Apr;54(4):365-9. Japanese.

PMID:
23666218
[PubMed - indexed for MEDLINE]
19.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Experts in Chronic Myeloid Leukemia.

Blood. 2013 May 30;121(22):4439-42. doi: 10.1182/blood-2013-03-490003. Epub 2013 Apr 25.

PMID:
23620577
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Molecular target therapy for myelodysplastic syndrome].

Morita Y, Tanaka H, Matsumura I.

Nihon Rinsho. 2012 Nov;70 Suppl 8:508-12. Japanese. No abstract available.

PMID:
23513892
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk